Department Of Pediatrics
-
Fellowships reflect Michal’s deep commitment to children
Mary Michal, MD,’60, may have entered Vanderbilt University School of Medicine by mistake, but she’s remained devoted to its mission by design. Read MoreDec 7, 2017
-
Trevathan named director for the Vanderbilt Institute for Global Health
Edwin Trevathan, MD, MPH, a pediatric neurologist and epidemiologist who has previously held prominent university leadership positions at Washington University in St. Louis (director of Pediatric Neurology), St. Louis University (dean, School of Public Health) and Baylor University (Provost and Executive Vice President) as well as at the U.S. Centers for Disease Control and Prevention (CDC), has been appointed director of the Vanderbilt Institute for Global Health (VIGH), effective Jan. 1, 2018. Read MoreNov 20, 2017
-
Boosting sarcoma cell death
A compound identified at Vanderbilt represents a new lead for treating rare, aggressive childhood cancers called Ewing sarcomas. Read MoreOct 4, 2017
-
Delirium, benzos and the pediatric ICU
With other risk factors held equal, children who received a benzodiazepine sedative drug were nearly three times more likely to experience delirium – confused thought – the following day. Read MoreOct 2, 2017
-
Goal of new tissue-chip research is to assess efficacy of novel epilepsy drugs
An interdisciplinary team of Vanderbilt University researchers has received a two-year, $2-million federal grant to develop an “organ-on-chip” model for two genetic forms of epilepsy. Read MoreSep 20, 2017
-
Address highlights Pediatrics’ people, progress, growth
Steven Webber, MBChB, MRCP, delivered the annual State of the Department of Pediatrics address on Tuesday, with growth and quality improvement serving as recurring themes along with a focus on the department’s four mission areas — discovery, clinical care, education and advocacy, service and community partnerships. Read MoreSep 7, 2017
-
Doris Duke Foundation lauds Van Driest’s research
Sara Van Driest, M.D., Ph.D., who is developing methods for precision dosing of pediatric medications at Vanderbilt University Medical Center (VUMC), has received a 2017 Clinical Scientist Development Award from the Doris Duke Charitable Foundation. Read MoreJul 27, 2017
-
Bile acids, microbiota and colon cancer
Bile acids produced by a western diet alter the composition of the gut microbiota and promote intestinal carcinogenesis. Read MoreJul 5, 2017
-
Team investigates antiviral that inhibits SARS, MERS
A new antiviral drug candidate inhibits a broad range of coronaviruses, including the SARS and MERS coronaviruses, a multi-institutional team of investigators reports this week in Science Translational Medicine. Read MoreJun 29, 2017
-
Vanderbilt Pre-Diabetes Clinic tackles type 2 diabetes in children
In Middle Tennessee, where roughly one-third of children are overweight or obese, the risk of developing pediatric type 2 diabetes is high and the consequences can be serious. Read MoreJun 22, 2017
-
Patrick honored for neonatal abstinence syndrome research
Stephen W. Patrick, M.D., MPH, MS, has been chosen to receive the Nemours Child Health Services Research Award, recognizing his work surrounding neonatal abstinence syndrome, a drug withdrawal syndrome experienced by infants exposed to opioids while in utero. Read MoreJun 15, 2017
-
New screening model quickly spots acute kidney injury
Researchers at Vanderbilt University Medical Center (VUMC) have developed a screening tool intended to more quickly identify patients with acute kidney injury (AKI). Read MoreJun 8, 2017
-
Hepatitis C infections among pregnant women increasing
Hepatitis C infections among pregnant women nearly doubled from 2009-2014, likely a consequence of the country’s increasing opioid epidemic that is disproportionately affecting rural areas of states including Tennessee and West Virginia. Read MoreMay 11, 2017
-
Study finds male infants at increased risk for NAS
Male infants are more likely at birth than their female counterparts to be diagnosed with drug withdrawal symptoms, also known as neonatal abstinence syndrome (NAS), and to require treatment, according to a new Vanderbilt study published in Hospital Pediatrics. Read MoreMay 4, 2017
-
Clue to recurrent C. diff infection
Children who experience recurrent C. diff infections may have fecal inflammatory markers that could predict risk and improve management of these infections. Read MoreMay 1, 2017
-
American Thoracic Society lauds Young’s contributions
Lisa Young, M.D., associate professor of Pediatrics and Medicine in the Divisions of Pulmonary Medicine and Allergy, Pulmonary, and Critical Care Medicine, has been selected to receive this year's American Thoracic Society (ATS) Public Advisory Roundtable Excellence Award. Read MoreMar 9, 2017
-
Mutation raises heart block risk
A newly identified genetic risk factor for heart block after surgery may help guide the course of postoperative care. Read MoreMar 3, 2017
-
Clinical investigation society lauds impact of Crowe’s research
James Crowe Jr., M.D., director of the Vanderbilt Vaccine Center, is the 2017 recipient of the Stanley J. Korsmeyer Award given by the American Society for Clinical Investigation (ASCI), one of the nation’s oldest and most respected honor societies for physician-scientists. Read MoreMar 2, 2017
-
Callahan to lead Adolescent and Young Adult Health
S. Todd Callahan, M.D., MPH, associate professor of Pediatrics, has been named director of the Division of Adolescent and Young Adult Health. Read MoreMar 2, 2017
-
Crowe’s pediatric immune response research lauded
James Crowe Jr., M.D., director of the Vanderbilt Vaccine Center, is the 2017-2018 recipient of the Samuel Rosenthal Prize for Excellence in Academic Pediatrics. Read MoreFeb 23, 2017